Dose-Response Relationship of Essential Metallic Elements. The Application of Categorical Regression Example: Copper

Similar documents
Zinc: Issues and Update. Craig Boreiko, Ph.D. Ottawa May 2008

What are the challenges in addressing adjustments for data uncertainty?

Part 2. Chemical and physical aspects

Evaluating Methods for Quantifying Human Noncancer Health Risks: Case Study Application. Contract # EP-W (Work Assignment #77) REVISED DRAFT

Environmental Risk Assessment Toxicity Assessment

Chemical Name: Metolachlor ESA CAS: Synonyms: Ethanesulfonate degradate of metolachlor; CGA

Overview of US EPA Assessment Activities for Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS)

Approaches to Integrating Evidence From Animal and Human Studies in Chemical Assessments

Chemical Name: Metolachlor OXA CAS: Synonyms: Oxanilic acid degradate of metolachlor

An In Vitro Alternative For Predicting Systemic Toxicity. By: James McKim, Ph.D., DABT Chief Science Officer

Distinguishing between Mode and Mechanism of Action

Status of Activities on BPA

Tetrachloroethylene: Integrated Risk Information System (IRIS) Draft Toxicological Review Kate Z. Guyton, PhD DABT

STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO ESTABLISH AN ACUTE REFERENCE DOSE

Outline: risk assessment. What kind of environmental risks do we commonly consider? 11/19/2013. Why do we need chemical risk assessment?

ICH Topic S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals. Step 5

CHAPTER 7 TOXICITY ASSESSMENT

OECD GUIDANCE DOCUMENT FOR THE DERIVATION OF AN ACUTE REFERENCE CONCENTRATION (ARfC) Revision History

Case Study Summary: Appendix: Evaluation of Hazard Range for Three Additional Chemicals: Tetrachloroethylene, Chromium (VI) and Arsenic.

3rd European Conference on Copper in Plant Protection 15 th -16 th November in Berlin, Germany

Mathematical Framework for Health Risk Assessment

Sponsor / Company: Sanofi Drug substance(s): Docetaxel (Taxotere )

Trends in the Lifetime Risk of Developing Cancer in Ontario, Canada

DANIEL R. DOERGE U.S. Food and Drug Administration National Center for Toxicological Research Jefferson, AR

Dermal Occupational Exposure Limits. Their use in risk assessment

Biomarkers and risk assessment for Deoxynivalenol

Title: Scientific principles for the identification of endocrine disrupting chemicals a consensus statement

APPLICATION FOR AUTHORISATION: ESTABLISHING REFERENCE DNELs FOR 1-BROMOPROPANE (1-BP)

Considerations of maternal toxicity in classification. George Daston

Benchmark Dose Modeling Cancer Models. Allen Davis, MSPH Jeff Gift, Ph.D. Jay Zhao, Ph.D. National Center for Environmental Assessment, U.S.

Composition-based risk (and benefit) assessment

Dose response relationships: biological and modeling aspects

APPLICATION FOR AUTHORISATION: ESTABLISHING REFERENCE DNELS FOR BBP

Dietary Risk Assessment of Nitrates in Cyprus and the relevant uncertainties

EFSA working group on BPA assessment protocol. Ursula Gundert-Remy Chair of the EFSA Working Group BPA assessment Protocol

How to assess effects data sets for metals hazard identification and risk characterization.

Tissue Dose Based Risk Assessments

Current status of Benchmark Dose Modeling for 3-Monochloropropane-1,2-diol (3-MCPD)

DOSE SELECTION FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS *)

Quantitative Risk Assessment: An Overview and Discussion of Emerging Issues. Anne-Marie Nicol, PhD

BUNDESINSTITUT FÜR RISIKOBEWERTUNG

DANIEL R. DOERGE U.S. Food and Drug Administration National Center for Toxicological Research Jefferson, AR

Dr. Josef Schlatter Member of the Scientific Committee and EFSA s WG on Novel Foods

The Scientific Rationale for Deriving Database and Toxicodynamic Uncertainty Factors for Reproductive or Developmental Toxicants

Assessing Health Impacts of Diverse Mixtures in the Environment

Human Health Risk Assessment Overview [For the APS/OPP Roundtable]

Iron. (2) Microminerals

STATISTICS IN CLINICAL AND TRANSLATIONAL RESEARCH

Application of human epidemiological studies to pesticide risk assessment

Study No. 178-CL-008 Report Final Version, 14 Dec 2006 Reissued Version, 18 Jul 2011 Astellas Pharma Europe B.V. Page 13 of 122

Pesticide Risk in Perspective

Multiple Data Sources Multiple Endpoints

5.36 THIOPHANATE-METHYL (077)

Topic 3.13 Use of NOAEL, benchmark dose, and other models for human risk assessment of hormonally active substances*,

Incorporating Computational Approaches into Safety Assessment

The role of biokinetics in in vitro tests and the interpretation of results. Emanuela Testai

FARM TO TABLE: PESTICIDE RESIDUES AND RISK ASSESSMENT

- draft scientific opinion -

Specific aspects for PNEC derivation for metals. P. Van Sprang, F. Verdonck, M. Vangheluwe

Robert G. Sussman, Ph.D., DABT Managing Principal, Eastern Operations. SafeBridge Consultants, Inc. Mountain View, CA New York, NY Liverpool, UK

Risk Characterization

Digging into copper & trace minerals M. Faulkner, PhD

Development of NJ Human Health-based Criteria and Standards

The Role of Simulation in Assessing Extrapolation Assumptions

Glycinates Animal Nutrition G-ENL/MT, G-ENL/MP

Statistical Analysis Plan (SAP)

Pattern of lipid biomarkers and risk of cardiovascular disease

Poly-fluoroalkyl substances (PFASs), also called perfluoroalkyl substances (PFASs)

RISK MANAGEMENT OPTION ANALYSIS CONCLUSION DOCUMENT

EPA Health Advisory for PFOA and PFOS Drinking Water

Methodologies for development of human health criteria and values for the lake Erie drainage basin.

Is There a Need to Enhance Transparency of Decision-Making Process? Robert Russell, M.D. Tufts University Boston, MA

Regulatory Toxicology and Pharmacology

Advanced IPD meta-analysis methods for observational studies

Guidelines of the Scientific Committee on Food for the development of tolerable upper intake levels for vitamins and minerals

Experiences with Exposure Models for Estimating the Bioavailability of Lead (Pb) in Children in the EU

Dissolvable Tobacco Products: Chemistry & Toxicology

T-2, HT-2 2 and deoxynivalenol (DON) in malting barley and malt

Nutritional and Toxicological Aspects of Manganese Intake. Annette Santamaria, PhD, MPH, DABT ENVIRON International Corporation May 6, 2008

Case 3 Acute inhalation of 60 Co. James Marsh

Biostatistics II

Hexavalent Chromium Oral Reference Dose

Graphical display of population data

Common Misunderstandings of Survival Time Analysis

5.15 HEXYTHIAZOX (176)

Logistic regression. Department of Statistics, University of South Carolina. Stat 205: Elementary Statistics for the Biological and Life Sciences

Diagnostic methods 2: receiver operating characteristic (ROC) curves

A weight-of-evidence approach for setting OELs for poorly soluble, low-toxicity nanoparticles

The Cost Effectiveness of Omacor post-myocardial infarction in the Irish Healthcare Setting

Supplementary Online Content

CLINICAL BIOSTATISTICS

Key Aspects of U.S. EPA s External Review Draft Toxicological Review of Trichloroethylene (TCE)

The EFSA scientific opinion on lead in food

Data Package of the Peer Consultation Meeting on the Chloroacetanilide Degradates. May 11 th 12 th, Northern Kentucky University, METS Center

TTC NON-CANCER ORAL DATABASES

From Biostatistics Using JMP: A Practical Guide. Full book available for purchase here. Chapter 1: Introduction... 1

EVALUATION OF POLYCYCLIC AROMATIC HYDROCARBONS IN CLAY TARGET FRAGMENTS AND SURFACE SOIL AT SHOT GUN RANGE SITES Presenter: Glenn Hoeger and Brian

Step by Step Approach for GPS Risk Assessment

The European Commission non-food Scientific Committees Scientific Committee on consumer safety - SCCS

Fitting discrete-data regression models in social science

Transcription:

Dose-Response Relationship of Essential Metallic Elements The Application of Categorical Regression Example: Copper

Problem: Dose-response relationship for essential trace elements is complex Highly Abnormal Essentiality Highly Abnormal Deficiency Excess Response Zone of conflict Homeostasis Zone of conflict Response Normal Normal Very Low Dose (Concentration) Very High

Outline Modeling Methods NOAEL/LOAEL Benchmark Modeling Overview of Categorical Regression Background Applications CatReg Software Copper Risk Assessment JTEH Review Copper Database Preliminary Results Future Directions

Modeling Methods NOAEL/LOAEL Simple and traditional method Limited use of the available dose-response information Single dose-time data point Little uncertainty characterization Benchmark Dose Entire dose-response curve is utilized instead of a single dose Quantitative uncertainty characterization Responses within experimental range are used Empirical curve-fitting

Categorical Regression Can be used when mechanistic models are lacking & insufficient evidence is available to support a complex dose-response relationship Can be used to model multiple studies and endpoints simultaneously using a common toxicity metric A dose-response model may be fitted to data where only severity ratings are available

Categorical Regression & Copper Heterogeneity amongst available experimental studies on copper (specie, dose, endpoints, route of exposure), limits the application of traditional methods Traditional dose-response approaches where RfD: NOAEL/UF may bring the resulting value into the deficiency range

Advantages of Categorical Regression Define the relationship by increasing severity of response Ensures that the best available evidence is utilized and integrated into a single quantitative analysis Can combine data from multiple studies & utilize information on multiple species Curve no longer based on the most sensitive strain, specie, sex may be more predictive of actual human risk Scatter demonstrated in regression provides useful information on the uncertainty in the dose-response model

CatReg Capabilities A computer program developed to support toxicologists & health scientists conduct exposureresponse analyses Developed by U.S. EPA Executes a regression analysis of the severity scores and exposure parameters Three statistical models available: Logistic (logit) Normal (probit) Gumbel (log-log)

CatReg Capabilites Determine whether the coefficients for concentration and time differ by severity level Methods for estimation and hypothesis testing of model parameters Range of options for sensitivity analysis Can produce graphical displays of data and fitted models Combine data sets from different experiments Statistical testing for differences between combined experiments

Monograph II: Copper Risk Assessment

Data Collection Process Review scientific literature Identifying papers on copper toxicity due to excess and deficiency Review papers for quality Select key studies using a consensus approach

Hazard Identification Criteria Consensus approach reviewed over 600 papers for hazard identification and dose response assessment Excluded studies included: Exposures in utero No reliable level of exposure Depletion / repletion phases Only pharmacokinetic data Case reports with no known exposure duration

Criteria Used for Exclusion Most Useful Least Useful 1 2 3 4 5 Multiple dose or multiple outcomes from intact animals or humans Adequate Reporting Physiological Measures Multiple or single dose from intact animals or humans Fairly Good Reporting Likely to yield useful information Single dose or clinical study / case report with indeterminate dose Tracer or PK Study Info re. body burden or kinetics No dose information Physiological information Review No Utility Change in time Points Mechanistic or cellular effects Cellular effects

Results of the Hazard Identification ~600 Papers Selected through criteria: 92 papers Animal Species (6) # Doses Single dose Repeat dose Systems Affected (24) Routes of administration Water Capsule Feed Copper species (~10)

Results of the Hazard Identification 92 papers example closely and NOAELs and Benchmark Doses were determined Each endpoint assigned a severity score of either 0, 1, 2, or 3 for the categorical regression, where: 0=homeostasis 1=enzyme changes 2=metabolic perturbations 3=gross toxicity or deficiency Both excess and deficiency studies were based on the same scoring system

Severity Scoring Summary Deficiency Endpoints Copper Burden; metallothionein; urine copper Loss of Cu-dependent enzyme function (SOD); Changed blood cell # or function Organ weight changes; plasma glucose/insulin; heart rate; EKG changes; minor histopatholgy; white blood cell activity/counts Mortality; gross histopathology reproductive function changes Severity Score 0 1 2 3 Toxicity Endpoints Cu burden; metallothionein; urine Cu Changes in cholesterol and triglyceride levels in blood/liver; large Cu burden; body weight; nausea; diarrhea; enzyme changes without histopathology Body weight; anemia; hemolysis; vitamin levels; liver enzymes; inflammation; organ weight changes Death; gross histopathology

Copper Database Total of 3,844 severity scores assigned Maximum severity scores (312) selected from each dose group in each study Marker Ref.id Exp Group Species Sex mg/kg bw Weeks GpSize BestNum 1 1 1 1 MU F 0.06 5.6 1 1 2 1 1 2 MU F 0.6 5.6 1 2 3 4 1 1 RA M 0.02 6 1 1 4 4 1 2 RA M 0.25 6 1 2 5 4 1 3 RA M 0.8 6 1 3 6 8 1 1 MU F 0 4 1 1 7 8 1 2 MU F 1.5 4 1 3

Interspecies Scaling Interspecies scaling based on four dose metrics: body weight: mg/kg bw/day surface area: bw 2/3 intermediate: bw 3/4 (Travis & White, 1988) total intake: mg/day

Dose - Duration Curves for Toxicity due to Copper Excess

ED10 Dose - Duration Curves for Severity Level 3 for Toxicity due to Copper Excess (with 95% confidence limits) for Human (n=20) Dose ( mg/kg bw/day ) 0.00010.001 0.01 0.1 1 10 100 1000 10000 Severity Level 0 Severity Level 1 Severity Level 2 Severity Level 3 Censored 0 50 100 150 Duration ( Days )

ED10 Dose - Duration Curves for Severity Level 3 for Toxicity due to Copper Excess Dose ( mg/kg bw/day ) 0.00010.001 0.01 0.1 1 10 100 1000 10000 0 50 100 150 Duration ( Days ) Human Mice Rats

ED10 Dose Response Curves for Severity Level 3 for Toxicity due to Copper Excess following 100 Days Exposeure for Human (n=20) Pr (Severity >= 3 ) 0.0 0.5 1.0 0.001 0.01 0.1 1 10 100 1000 10000 Dose ( mg/kg bw/day )

Comparison of Scaling Methods

ED10 for Severity Level 3 for Toxicity due to Copper Excess following 100 Days Exposure (with 95% confidence limits) Rats [ ] Mice [ ] Human [ ] -10-5 0 5 10 log 10 Dose ( mg/kg bw/day )

ED10 for Severity Level 3 for Toxicity due to Copper Excess following 100 Days Exposure (with 95% confidence limits) Rats [ ] Mice [ ] Human [ ] -10-5 0 5 10 log 10 Dose ( mg/kg bw 2/3 /day )

ED10 for Severity Level 3 for Toxicity due to Copper Excess following 100 Days Exposure (with 95% confidence limits) Rats [ ] Mice [ ] Human [ ] -10-5 0 5 10 log 10 Dose ( mg/kg bw 3/4 /day )

ED10 for Severity Level 3 for Toxicity due to Copper Excess following 100 Days Exposure (with 95% confidence limits) Rats [ ] Mice [ ] Human [ ] -10-5 0 5 10 log 10 Dose ( mg/day )

ED10 for Severity Level 3 for Toxicity due to Copper Deficiency following 100 Days Exposure (with 95% confidence limits) Rats [ ] Mice [ ] Human [ ] -10-5 0 5 10 log 10 Dose ( mg/day )

Model 1: Cumulative Odds (parallel dose response curves)

Dose ( mg/day ) 0.0001 0.001 0.01 0.1 1 10 100 1000 10000 ED10 Dose - Duration Curvesfor Toxicity due to Copper Excess (with 95% confidence limits) for Human (n=20); Model: Cumulative Odds Severity Level 0 Severity Level 1 Severity Level 2 Severity Level 3 Censored 0 50 100 150 Duration ( Days )

Model 2: Unrestricted Cumulative (non-parallel dose-response curves)

Dose ( mg/day ) 0.0001 0.001 0.01 0.1 1 10 100 1000 10000 ED10 Dose - Duration Curves for Toxicity due to Copper Excess (with 95% confidence limits) for Human (n=20); Model: Unrestricted Cumulative 0 50 100 150 Duration ( Days ) Severity Level 0 Severity Level 1 Severity Level 2 Severity Level 3 Censored

Future Analysis Update the current copper database Include additional species Select Model: Restricted vs unrestricted Cumulative vs conditional odds Exposure duration (10 100 days) Select final dosimetry (mg/day?) Examine multiple levels of severity Conduct a qualitative analysis of all data to determine the endpoints of the homeostatic range for copper Consider uncertainty factors for sensitive individuals